Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

How do you decide to start (or not start) treatment for NTM-LD?

Source: Guideline-Endorsed Answers to Key Questions in Nontuberculous Mycobacterial Lung Disease Management
Keira A. Cohen, MD
Program Director
person default
David E. Griffith, MD
Princy N. Kumar, MD, FIDSA, MACP
Released: November 19, 2021 Expiration: No longer available for credit

Video Chapters

NTM Lung Disease in 2021
Diagnosis
Treatment
Monitoring
Treatment Refractory NTM-LD
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Insmed Incorporated

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings